AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Total projects in clinical development pipeline by Year
Total projects in clinical development pipeline (count)
AstraZeneca Total projects in clinical development pipeline: 197 in FY2025, up 3.1% from a year earlier.
Where the FY2025 figure comes from
“197 projects in development pipeline | 20 NMEs in late-stage pipeline | 125 NME or major LCM projects in Phase II or Phase III | 43 regulatory approvals in major markets (US, EU, CN, JP)”
Source: Clinical Trials Appendix (2025Q4) ↗
Reported in Clinical Trials Appendix (Quarterly & Annual Pipeline at a Glance).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total projects in clinical development pipeline (count) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 197 | +3.1% | Clinical Trials Appendix (2025Q4) ↗ |
| FY2024 | Dec 31, 2024 | 191 | +7.3% | Clinical Trials Appendix (2024Q4) ↗ |
| FY2023 | Dec 31, 2023 | 178 | – | Clinical Trials Appendix (2023Q4) ↗ |
Breakdown
What makes up total projects in clinical development pipeline
Cite this data
StockData. (2026). AstraZeneca Total projects in clinical development pipeline, annual FY2023–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/cta-total-projects
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.